Results 121 to 130 of about 4,557 (175)

Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early-Onset Androgenetic Alopecia: A Case-Control Study. [PDF]

J Cosmet Dermatol
Erden O, Yorulmaz A, Yalcin B.
europepmc   +1 more source

Who Tells the Story of the Treatment of Androgenetic Alopecia?-A Bibliometric Analysis From 2003 to 2023. [PDF]

J Cosmet Dermatol
Sun Y, Lu M, Gao X, Liu Y, Ren J, Wang Y, Cai X.   +6 more
europepmc   +1 more source

Overcoming the Low Bioavailability of Apigenin: The Therapeutic Efficacy for Androgenetic Alopecia Through Topical Administration. [PDF]

Food Sci Nutr
Peng Y, Zhou H, Sun Y, Huang D, Zhao C.
europepmc   +1 more source

Consensus Recommendations for the Management of Androgenetic Alopecia in Egypt: A Modified Delphi Study. [PDF]

Clin Cosmet Investig Dermatol
Mohy SM, Abozeid MF, Seoudy WM, Elshahid A, Moubasher AEA, Hassan A, Elmorsy E, Hofny ERM, Mohamed EM, Saleh HM, Sabry H, Gharib K, Gaber MA, Hegazy MS, Atwa MA, Moftah N, Bedair NI, Mohammed NE, Esmat S, Ameen T, Hussein T, Gohary YM, Rageh MA.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Androgenetic alopecia

Nature Reviews Disease Primers
Androgenetic alopecia (AGA) is a condition of scalp hair growth characterized by progressive miniaturization of hair follicles and a reduction in the number of active follicles. In general, frontal, mid-scalp and crown hair follicles in postpubescent men and in postmenopausal women are susceptible to AGA.
Yingzi Liu, Antonella Tosti, Etienne C. E. Wang, Stefanie Heilmann-Heimbach, Crystal Aguh, Francisco Jimenez, Sung-Jan Lin, Ohsang Kwon, Maksim V. Plikus   +8 more
  +6 more sources

Androgenetic alopecia

International Journal of Dermatology, 1999
No abstract ...
Tosti A., Piraccini B. M.
openaire   +3 more sources

Androgenetic Alopecia

Endocrinology and Metabolism Clinics of North America, 2007
Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (eg, finasteride, minoxidil, or a combination of both), the progression can ...
Nina, Otberg, Andreas M, Finner, Jerry, Shapiro   +2 more
openaire   +2 more sources

Androgenetic alopecia.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2014
Androgenetic alopecia (AGA) is the most common form of alopecia, affecting up to 80% of men and 50% of women in the course of their life. AGA is caused by a progressive reduction in the diameter, length and pigmentation of the hair. Hair thinning results from the effects of the testosterone metabolite dehydrotestosterone (DHT) on androgen-sensitive ...
PIRACCINI, BIANCA MARIA, ALESSANDRINI, AURORA MARIA   +1 more
openaire   +4 more sources

Management of Androgenetic Alopecia

American Journal of Clinical Dermatology, 2000
Androgenetic alopecia is by far the most common cause of hair loss. It affects approximately 50% of men by the age of 50 and 20 to 53% of women by the age 50. Although it is a medically benign condition, it is a significant psychosocial issue for many patients. Various different treatment options are now available for androgenetic alopecia.
C, Bolduc, J, Shapiro
openaire   +2 more sources